Drugplain

NOVOEIGHT

antihemophilic factor recombinant · KIT · Novo Nordisk

No Recall History
Plain English

Novoeight is a recombinant antihemophilic factor used to treat hemophilia A by helping blood clot properly. It comes as a kit that you prepare and inject as directed by your healthcare provider.

Key Facts

Brand Name
NOVOEIGHT
Generic Name
antihemophilic factor recombinant
NDC Code (Product)
0169-7825
Manufacturer
Novo Nordisk
Dosage Form
KIT
Marketing Status
Application #
BLA125466
Marketing Start
04/01/2015

Recall History

No Recall History

Frequently Asked Questions

What is NOVOEIGHT used for?

Novoeight is a recombinant antihemophilic factor used to treat hemophilia A by helping blood clot properly. It comes as a kit that you prepare and inject as directed by your healthcare provider.

Is NOVOEIGHT a controlled substance?

NOVOEIGHT is not classified as a controlled substance by the DEA.

What is the generic name for NOVOEIGHT?

The generic name for NOVOEIGHT is antihemophilic factor recombinant. There are 5 other brand versions of antihemophilic factor recombinant.

What is the NDC code for NOVOEIGHT ?

The NDC (National Drug Code) for NOVOEIGHT is 0169-7825, listed by Novo Nordisk.

Product NDC

0169-7825

Package NDC

0169-7825-01

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)